10-Q: Greenlane Holdings Reports Steep Q2 Revenue Drop, Widened Loss
Quarterly Report
Greenlane Holdings, Inc. reported a 70% decline in net sales and a significantly widened net loss for the second quarter of 2025, despite a substantial increase in cash and working capital driven by a recent private placement and debt repayments.
Summary
- Net sales for the three months ended June 30, 2025, decreased by 70% to $0.8 million, compared to $2.7 million for the same period in 2024.
- Gross profit for the three months ended June 30, 2025, was $2 thousand, a 100% decrease from $1.0 million in the prior year, resulting in a 0% gross margin.
- Net loss for the three months ended June 30, 2025, increased by 409% to $3.2 million, compared to $0.6 million for the same period in 2024.
- For the six months ended June 30, 2025, net sales decreased 70% to $2.3 million, and net loss increased 38% to $7.1 million.
- Cash on hand significantly increased to $5.7 million as of June 30, 2025, from $0.9 million at December 31, 2024, primarily due to a $25.0 million private placement in February 2025.
- Working capital improved substantially to $16.3 million as of June 30, 2025, from $1.5 million at December 31, 2024.
- The company repaid $8.0 million in total debt during the six months ended June 30, 2025.
- A one-for-750 reverse stock split was effected on June 25, 2025, retroactively adjusting all share and per share amounts.
Sentiment
Score: 3
Explanation: While the company successfully raised capital and improved its balance sheet liquidity, the core operational performance shows significant deterioration with a 70% revenue decline and near-zero gross profit for the quarter. The ongoing net losses and explicit 'going concern' warning indicate severe financial distress and high risk, outweighing the positive financing activities.
Positives
- Cash on hand increased significantly to $5.7 million as of June 30, 2025, from $0.9 million at December 31, 2024.
- Working capital improved substantially to $16.3 million as of June 30, 2025, from $1.5 million at December 31, 2024.
- Successfully raised approximately $25.0 million through a private placement in February 2025.
- Repaid $8.0 million in total debt during the six months ended June 30, 2025, significantly reducing interest expense.
- Regained compliance with Nasdaq's Bid Price Rule as of July 29, 2025.
- Implemented strategic marketing partnerships and new distribution agreements to diversify product offerings and expand reach.
- Completed a restructuring of the sales team and reduced headcount to align costs with revenue.
- Made progress in consolidating and streamlining office, warehouse, and distribution operations.
Negatives
- Net sales for the three months ended June 30, 2025, decreased by 70% to $0.8 million compared to $2.7 million in the prior year period.
- Gross profit for the three months ended June 30, 2025, was $2 thousand, a 100% decrease from $1.0 million in the prior year, resulting in a 0% gross margin.
- Net loss for the three months ended June 30, 2025, increased by 409% to $3.2 million compared to $0.6 million in the prior year period.
- Net cash used in operating activities significantly increased to $7.9 million for the six months ended June 30, 2025, from $0.4 million in the prior year period.
- The company continues to incur significant net losses and anticipates continued losses for the foreseeable future.
- The sale of the EU subsidiary, Shavita B.V., is in dispute due to unfulfilled consideration obligations.
Risks
- Substantial doubt about the company's ability to continue as a going concern due to significant operating and net losses and cash used in operations.
- No assurance that management's plans to improve liquidity and profitability (cost reduction, revenue increase, strategic partnerships, seeking additional capital) will be successful.
- Risk of potential delisting from Nasdaq if the company fails to maintain listing standards, despite current compliance, as evidenced by the one-year Discretionary Panel Monitor.
- Adverse effects from new tariffs and evolving trade policy disputes between the United States and China, potentially impacting pricing, customer demand, and costs.
- Dependence on third-party suppliers and vulnerability to transportation risks.
- Exposure to various legal claims, lawsuits, and administrative proceedings, including antitrust actions and a False Claims Act investigation related to a PPP loan.
- Inability to maintain adequate internal controls over financial reporting, with material weaknesses identified and not yet remediated.
Future Outlook
Management believes that cash on hand, including proceeds from the February 2025 Private Placement, and cash flow from operations will be sufficient to fund working capital and capital expenditure requirements for the next 12 months. This is contingent on successful execution of plans to further reduce operating costs, increase revenue through new products and customer acquisition, execute strategic partnerships, and potentially seek additional capital through debt or equity securities.
Management Comments
- "We are intensely focused on making our business profitable and well-capitalized for long-term sustainability."
- "The recent reorganization of the sales team including new sales leadership and the recruitment of a stronger sales team in 2025 negatively impacted sales in the first half of the year. The new structure is designed to accelerate sales, improve customer experience, and increase efficiency throughout the sales process."
- "We have significantly reduced our headcount and associated salary expenses, focusing on maintaining a core group of key employees as we collectively right-size the business."
- "We believe that our cash on hand that includes cash raised in the February 2025 Private Placement and the cash flow that we generate from our operations will be sufficient to fund our working capital and capital expenditure requirements and other liquidity requirements associated with our existing operations, for the next 12 months."
Industry Context
Greenlane Holdings operates within the cannabis accessories, vape devices, and lifestyle products industry, serving both B2B (licensed dispensaries, smoke shops, MSOs) and direct-to-consumer channels. The company acknowledges the challenging economic landscape within the cannabis industry, which has contributed to weaker demand. Its strategic initiatives, such as expanding distribution platforms (Mainstem B2B) and diversifying product offerings (pet & wellness, new vaporizer lines), reflect efforts to adapt to market conditions and drive growth in a competitive environment.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to assess Greenlane Holdings' performance against global industry benchmarks.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Sales Leadership | NA | New Sales leadership (unnamed) | June 2025 | Restructuring of Sales team to provide enhanced service and support sales plan execution. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reverse Stock Split | A one-for-750 reverse stock split of issued and outstanding shares of Common Stock was effected on June 25, 2025. All share and per share amounts have been retroactively adjusted. | 2025-06-25 | Aimed at increasing per-share price to maintain Nasdaq listing compliance, but does not change underlying company value. Reduces number of outstanding shares. |
| Internal Control Material Weaknesses | Disclosure controls and procedures were not effective as of June 30, 2025, due to material weaknesses in internal control over financial reporting, specifically related to ineffective user access controls in the ERP system. | 2025-06-30 | Indicates potential for misstatements in financial reporting and operational inefficiencies. Remediation efforts are ongoing but not yet complete. |
| Equity Incentive Plan Amendment | Stockholders approved a fourth amendment to the 2019 Equity Incentive Plan on December 31, 2024, increasing authorized shares for future awards to an aggregate of 424 shares and including an evergreen provision to replenish the share pool to 15% of outstanding shares. | 2024-12-31 | Increases potential for equity-based compensation and potential future dilution for shareholders. |
Legal Proceedings
- Pryor Cashman arbitration for $320,511.48 in unpaid legal invoices (Company intends to dispute).
- Three consolidated direct purchaser antitrust class actions (Earths Healing, Inc.; Redbud Roots Inc.; Summit Industrial Solutions LLC) against U.S. Distributors of Ccell products, including Greenlane Holdings, Inc. (Company believes cases are baseless and without merit).
- Crossmark, Inc. breach of contract suit against subsidiary Warehouse Goods, LLC for $297,181.90 (Company intends to defend vigorously).
- Civil Investigation Demand regarding an investigation into a 2020 Federal Payment Protection Program (PPP) loan of approximately $1.9 million for a subsidiary (Company cannot assess likely outcome, potential for treble damages).
- S.K et al consumer class action antitrust action against U.S. distributions of Ccell products, including Greenlane Holdings, Inc.
- Vaporous Technologies, Inc. suit for liquidated damages of $664,289.43 under a September 2020 Manufacturing Agreement against Warehouse Goods, LLC.
Related Party Transactions
- Exclusive distribution partnership with Green Gruff, where Renah Persofsky, a Greenlane Director, is a Principal Owner.
- Lawsuit filed against Blum Holdings Inc. for approximately $0.4 million in accounts receivable, where Nicholas Kovacevich, former Chief Corporate Development Officer, owns capital stock and serves on the board (judgment received in favor of the Company).
- Secured Bridge Loan Lender, Synergy Imports, LLC, had principals who were employees of the Company at the time, though not executive officers or directors.
Stakeholder Impact
- Shareholders: Significant dilution from past and recent warrant exercises and private placements, impact of reverse stock split on share count, ongoing risk of delisting (though currently compliant), and potential for further dilution from future capital raises.
- Employees: Headcount reductions implemented as part of cost-saving measures, impacting employment levels.
- Customers: Restructuring of the sales team and new distribution agreements aim to provide enhanced service and product assortment.
- Suppliers: Renegotiation of vendor and supplier partnership terms and improved working capital arrangements.
- Creditors: Significant debt repayment of $8.0 million reduces overall indebtedness, improving the company's financial stability from a debt perspective.
Next Steps
- Further reducing operating costs through additional restructuring actions to align costs with revenue and achieve profitability.
- Increasing revenue by introducing new products and acquiring new customers.
- Executing on strategic partnerships accretive to margins and operating cash.
- Seeking additional capital through the issuance of debt or equity securities.
- Continuing to implement enhancements to company-wide risk assessment processes and control documentation.
- Improving control activities and procedures in certain accounting areas, including proper segregation of duties.
- Educating and training control owners regarding internal control processes.
- Monitoring continued compliance with Nasdaq listing rules, particularly the Bid Price Rule.
Key Dates
| Date | Description |
|---|---|
| 2023-07-31 | Company received cash from future receivables financing. |
| 2023-08-31 | Company received cash from future receivables financing. |
| 2023-09-22 | Company entered into a secured loan agreement (Secured Bridge Loan) with Synergy Imports, LLC for $2.2 million in new funds. |
| 2023-10-31 | Company received cash from future receivables financing. |
| 2023-11-30 | Company received cash from future receivables financing. |
| 2024-05-01 | Effective date of Asset Purchase Agreement and Loan Modification Agreement with Synergy Imports, LLC. |
| 2024-05-06 | Company, Warehouse Goods and Synergy entered into an asset purchase agreement. |
| 2024-06-07 | Company entered into a subscription agreement for a note payable with Cobra Alternative Capital Strategies, LLC. |
| 2024-08-07 | Company issued a note in the principal amount of $3,237,269 to Cobra. |
| 2024-08-12 | Company entered into a securities purchase agreement for aggregate gross cash proceeds of $6.5 million (August 2024 Private Placement). |
| 2024-10-29 | Company entered into an Exchange Agreement with its Senior Subordinated Lender and Cobra, exchanging $4.6 million of debt for a new $4.0 million Exchange Note and extending Cobra's note maturity to October 29, 2025. |
| 2024-11-13 | Pryor Cashman made a demand for arbitration for unpaid legal invoices. |
| 2024-11-15 | Vaporous Technologies, Inc. brought a suit for liquidated damages against Warehouse Goods, LLC. |
| 2024-12-16 | S.K et al brought a consumer class action antitrust action against four U.S. distributions of Ccell products, including Greenlane Holdings, Inc. |
| 2024-12-17 | Crossmark, Inc. brought a breach of contract suit against subsidiary Warehouse Goods, LLC. |
| 2024-12-31 | Company's stockholders approved a fourth amendment and restatement of the 2019 Plan, increasing authorized shares for awards. |
| 2025-01-01 | Company announced exclusive distribution partnership with Green Gruff. |
| 2025-01-11 | Company announced USPS approval of PACT Act Exemption. |
| 2025-02-05 | Original due date for the Cobra Note. |
| 2025-02-11 | Earths Healing, Inc. brought a purchaser class action antitrust action against four U.S. Distributors of Ccell products, including Greenlane Holdings. Inc. |
| 2025-02-18 | Company entered into definitive agreements for a $25.0 million private placement (February 2025 Offering) and an Exchange Agreement with warrant holders. |
| 2025-02-19 | Company consummated the February 2025 Private Placement. |
| 2025-02-25 | Company received a Civil Investigation Demand regarding an investigation into a 2020 PPP loan. |
| 2025-03-31 | Company launched on Mainstem B2B procurement marketplace and selected Cannabis Creative Group for marketing. |
| 2025-04-01 | Company entered into distribution agreements with Greentank Technologies and ALD Group Limited. |
| 2025-04-10 | Redbud Roots Inc. brought a purchaser class action antitrust action against four U.S. Distributors of Ccell products, including Greenlane Holdings. Inc. |
| 2025-04-17 | Summit Industrial Solutions LLC. brought a purchaser class action antitrust action against four U.S. Distributors of Ccell products, including Greenlane Holdings. Inc. |
| 2025-05-05 | Company received a notification letter from Nasdaq regarding discretionary delisting authority. |
| 2025-05-30 | Date of Nasdaq Hearings Panel decision. |
| 2025-06-16 | Company filed Certificate of Amendment for one-for-750 reverse stock split. |
| 2025-06-25 | Effective date of the one-for-750 reverse stock split. |
| 2025-06-30 | End of the quarterly period covered by the report. |
| 2025-07-29 | Company notified by Nasdaq of compliance with Bid Price Rule and imposition of one-year Discretionary Panel Monitor. |
| 2025-08-14 | Date of filing of the 10-Q report. |
| 2025-10-29 | New Maturity Date for Cobra Notes after amendment. |
Recommendation
strong sellDespite a successful capital raise that significantly improved cash and working capital, Greenlane Holdings' core business performance is severely deteriorating, evidenced by a 70% year-over-year revenue decline and a 100% drop in gross profit for the quarter. The company continues to incur substantial net losses and explicitly states a 'going concern' uncertainty, indicating a high risk of future financial instability. While debt has been reduced, the fundamental operational challenges and ongoing legal proceedings present significant headwinds. The Nasdaq compliance is tenuous, with a one-year monitor imposed. Given the severe operational losses and the high probability of continued losses, the stock represents a high-risk investment with significant downside potential, making it a strong sell for investors.
Keywords
Greenlane Holdings, GNLN, SEC filing, 10-Q, quarterly report, financial results, cannabis accessories, vape products, distribution, corporate governance, liquidity, going concern, reverse stock split, private placement, debt repayment, legal proceedings, Nasdaq listing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.